HistoIndex, a global leader in stain-free digital pathology solutions for managing fibrotic diseases, has announced the ...

HistoIndex, a global leader in stain-free digital pathology solutions for managing fibrotic diseases, has announced the launch of their first Laboratory Developed Test (LDT) FibroSIGHTtm ? now ...

AI-powered models can analyze large datasets in real-time, optimizing organ distribution across wider geographic regions.

Rise in prevalence of cancer and the necessary attention in early diagnosis and treatment to boost market demand, States Fact.MRRockville, MD, ...

ucsd.edu Objective Patients with non-alcoholic fatty liver disease ... with contemporaneous MRE and biopsy-proven NAFLD. Non-alcoholic steatohepatitis-Clinical Research Network-Histologic Scoring ...

Laparoscopic liver resection in posterosuperior segments was linked to a shorter functional recovery time and postoperative ...

Metabolic dysfunction-associated steatohepatitis (MASH) is a polygenic disorder influenced by multiple genes, but their specific roles in the progression of disease remain unknown. To address this gap ...

BACKGROUND: Despite the high morbidity and mortality of heart failure with preserved ejection fraction (HFpEF), treatment ...

The scoring method, called the Tumor Immune Microenvironment Spatial System, or TIMES, is the first tool in the world to ...

FibroScan overestimated advanced fibrosis and cirrhosis in patients with class 3 obesity and metabolic dysfunction-associated steatotic liver disease.

Furthermore, the intrinsic capacity of the liver to improve after exposure to ... [73] In a clinical trial performed in 170 patients with a positive biopsy for cirrhosis, followed up for 2 to ...

Diagnosis was confirmed by autopsy or needle biopsy of the liver in 8 cases. Normally, the parotid glands are not palpable, and a concavity exists in the region between the superior ramus of the ...